SPR™ Therapeutics is commercializing a novel therapy for severe pain with its patented peripheral nerve stimulation products. The company's pipeline of neurostimulation pain therapies will exploit the same physiologic mechanism of action, proprietary technology and clinical approach.
The first product to be commercialized is the SMARTPATCH™ PNS System, which is a short-term, minimally invasive system that is simple to deliver and can be used for up to 30 days to stimulate electrically a peripheral nerve to relieve pain.
Initial JumpStart investment: April 2011
For more information on SPR Therapeutics, contact: Michael Lang